Hemocoagulation in coronavirus viral disease: analyses of the problem and our opinion

I. Bokarev; L. Popova

Статья

Hemocoagulation in coronavirus viral disease: analyses of the problem and our opinion

I. Bokarev, L. Popova,

2020

https://doi.org/10.30629/0023-2149-2020-98-6-405-413

The article provides an overview of the recent literature on the state of hemocoagulation in the viral disease COVID-19 caused by SARS-CoV-2. The issues of its pathogenesis are considered and assumptions are made about the possible benefits of patients from the use of medications that affect the platelet units.

Цитирование

Документы

Версии

1. Version of Record от 2020-11-26

Метаданные

Об авторах

I. Bokarev
Russian Association for the Study of Thrombosis, Hemorrhages and Vascular Pathology named after A.A. Schmidt–B.A. Kudryashova
L. Popova
Russian Association for the Study of Thrombosis, Hemorrhages and Vascular Pathology named after A.A. Schmidt–B.A. Kudryashova; First Moscow State Medical University of the Ministry of Health of the Russian Federation named after Sechenov I.M. (Sechenov University)

Название журнала

Clinical Medicine (Russian Journal)

Том

Выпуск

Страницы

405-413

Издатель

Medical Informational Agency Publishers

Тип документа

journal article

Тип лицензии Creative Commons

CC BY

Правовой статус документа

Свободная лицензия

Источник

dimensions

Поиск по репозиторию

Статья

Hemocoagulation in coronavirus viral disease: analyses of the problem and our opinion

Похожие публикации

Документы

Версии

Метаданные